Welcome to the Institute of Clinical Neuroimmunology
News
Klaus Faber Initiative for Progressive MS prolonged at the Institute of Clinical Neuroimmunology
Work of Lisa Gerdes and colleagues named by the Süddeutsche Zeitung as 2024 breakthrough
March 2025: Based on promising findings on the immune mechanisms that drive progression in multiple sclerosis (MS) the Klaus Faber foundation has prolonged their funding for a research initiative at the Institute of Clinical Neuroimmunology.
January 2025: The Süddeutsche Zeitung selects work by Lisa Gerdes and colleagues as a breakthrough discovery for 2024.
Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice
T–B cell cooperation in ectopic lymphoid follicles propagates CNS autoimmunity
April 2025 – Changes in the intestinal microbiota have long been associated with development of MS, but which changes are relevant for the pathogenic process remains largely unclear. Under the guidance of Emeritus Professor Hartmut Wekerle, the Gerdes lab and the Peters lab collaborated...
April 2025 – Meningeal lymphoid follicles (eLFs) are detected in many people with severe MS but their function is unclear. Here, the Peters lab together with the Kawakami, Beltrán and Kerschensteiner labs investigated the cellular processes inside eLFs in a model system, and could show ...
